
What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients
Fox News
"GLP-3" breakthrough drug retatrutide by Eli Lilly shows major weight loss in clinical trials. The triple-agonist medication targets three hormones, with positive results.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
The informal term "GLP-3" refers to a new triple-agonist drug that targets three hormones: GLP-1, GIP (glucose-dependent insulinotropic polypeptide, another naturally occurring hormone released by the gut after eating) and glucagon receptors. The most advanced example is retatrutide by Eli Lilly, according to clinical trial outcomes.
More Related News













